Healthcare providers in the U.S. now face a structural paradox: national healthcare spending surpassed $5.6T in 2025, yet most hospitals and health systems operate on margins of 2-5% while managing billion-dollar organizations through fragmented financial systems that deliver insight days or weeks after the fact. That information lag carries real consequences; last year alone, 20 hospitals filed for bankruptcy and 23 hospitals and emergency departments closed, while more than 700 rural hospitals currently sit at risk of shuttering because financial problems go undetected long enough to become irreversible. Translucent addresses this gap with an agentic AI platform that connects clinical, operational, and financial data into a unified layer and continuously identifies root causes in real time, replacing the manual reconciliation and spreadsheet-driven FP&A processes that have historically defined healthcare finance. The platform covers six domains – claims, labor, clinical output, P&L, budgets and forecasts, and contract economics and automates the analysis finance teams previously did by hand. Early customers report completing 97% of routine financial analysis without manual effort and a 56% increase in finance team capacity without adding headcount. With health systems including Northwestern Medicine, Duly Health and Care, and Springfield Clinic already on the platform, Translucent has established itself as healthcare’s financial operating system – a distinct category from the general-purpose billing and ERP tools most organizations currently piece together to run their finances.
AlleyWatch sat down with Translucent CEO and Founder Jack O’Hara to learn more about the business, its future plans, recent funding round, and much, much more…
Who were your investors and how much did you raise?
We recently raised a $27M Series A led by GV (Google Ventures), with participation from NEA, FPV Ventures, and Virtue VC. Prior to that, we raised a $7M seed round, bringing our total funding to $34M to date.
Tell us about the product or service that Translucent offers.
Translucent is an agentic AI platform that delivers real-time visibility and always-on root cause identification at scale, giving finance and clinical operators clarity to move the margin.
Today, most hospitals and medical groups operate with fragmented financial systems and manual FP&A processes. Finance teams spend the majority of their time pulling data from multiple systems, reconciling it in spreadsheets, and trying to piece together what’s actually happening in the business. By the time they have clarity, the window to act has often passed.
Translucent connects clinical, operational, and financial data into a unified layer and uses AI to automate the analysis that teams historically had to do by hand. Leaders get instant, real-time views into processes that take days to perform manually, so they can immediately understand what’s driving performance across things like physician productivity, labor costs, and service line margins.
Instead of reacting to problems months later, finance teams can identify risks and opportunities early and make adjustments that help maintain both financial stability and patient access.
What inspired the start of Translucent?
I spent years working inside healthcare organizations leading IT and transformation teams, and I kept running into the same problem: finance teams were spending most of their time pulling data together instead of actually making decisions.
One moment that stuck with me happened when our leadership team was trying to understand why one of our rural markets was suddenly underperforming financially. We pulled data from system after system, built spreadsheets, and tried to reconcile everything, but we still couldn’t get to the root cause fast enough. By the time we went to the board, we didn’t have clear answers, and the decision was made to shut the center down. Patients in that community suddenly had to drive hours to access care.
That experience made something very clear to me: hospitals and clinics shouldn’t have to choose between financial health and patient health. But today they often do, largely because the financial infrastructure that should help leaders understand what’s happening inside their organizations is still incredibly manual and slow.
Translucent was founded to change that. We give healthcare organizations the real-time financial insight they need to make better decisions before those kinds of outcomes become inevitable.
How is Translucent different?
Many tools in healthcare finance weren’t built for the idiosyncrasies of the business of healthcare. As a result, teams have to manually pull information from siloed systems, reconcile them, and map them according to healthcare business logic and organization-specific rules. That’s why so many finance teams spend the majority of their time working in spreadsheets just to understand what’s happening inside the organization.
Translucent takes a different approach. We’ve built an agentic AI platform that automates the manual analysis finance teams historically had to do by hand. By connecting clinical, operational, and financial data into a unified layer faster than any human team could, Translucent can surface real-time insights about what’s driving performance. That means finance teams can see risks and opportunities early enough to actually act on them.
What market does Translucent target and how big is it?
Translucent focuses on healthcare providers (hospitals, health systems, clinics and large medical groups), specifically the finance teams responsible for running those organizations.
In the U.S. alone, healthcare represents a multi-trillion-dollar market, yet most provider organizations operate on extremely thin margins and still rely on fragmented financial systems and manual analysis to manage their businesses. Our focus is helping those organizations modernize the financial engine that powers care delivery.
What’s your business model?
Translucent operates as a SaaS platform for healthcare providers, with organizations subscribing to the platform to automate financial analysis and gain real-time insight into their operations.
How are you preparing for a potential economic slowdown?
Healthcare is somewhat unique in that financial pressure on providers often intensifies during downturns. Hospitals and medical groups still have to deliver care, but margins get even tighter and leaders need better financial visibility to navigate that environment.
Our focus is staying disciplined on product and customers. When organizations are under pressure, tools that help them operate more efficiently and make better financial decisions tend to become even more critical.
What was the funding process like?
We were fortunate that the round was pre-empted and ultimately oversubscribed, which reflected the momentum we were seeing with customers and the urgency of the problem we’re solving.
What are the biggest challenges that you faced while raising capital?
One challenge is that healthcare finance is incredibly complex, and from the outside it’s not always obvious how manual a lot of the work still is.
So a big part of the conversation with investors was simply helping them see how the system actually operates day-to-day, and why that creates such a large opportunity for AI. Once they understood the scale of the problem and saw the traction we were already getting with customers, the conversation shifted pretty quickly toward how big this category could become.
What factors about your business led your investors to write the check?
The main thing that stood out was the scale and urgency of the problem. Our investors independently interviewed healthcare finance executives and had real appreciation for how underserved this segment is. Seeing that our sales cycle was half the time of the typical healthcare software sale was validation
The main thing that stood out was the scale and urgency of the problem. Our investors independently interviewed healthcare finance executives and had real appreciation for how underserved this segment is. Seeing that our sales cycle was half the time of the typical healthcare software sale was validation
What are the milestones you plan to achieve in the next six months?
Over the next six months, our focus is on deepening our AI capabilities and expanding adoption with healthcare providers. On the product side, we’re continuing to automate more of the manual financial analysis that teams still do today so the platform proactively surfaces the biggest risks and opportunities affecting margin.
Ultimately, our goal is to help more hospitals, clinics, and medical groups move from reactive financial reporting to real-time operational insight.
What advice can you offer companies in New York that do not have a fresh injection of capital in the bank?
Focus relentlessly on solving a real, urgent problem for your customers. When you’re building something people genuinely need, revenue and momentum become the strongest signals you can create.
Where do you see the company going now over the near term?
Over the near term, our focus is scaling with healthcare providers that are under real financial pressure. The more organizations that operate this way, the more sustainable the system becomes.
What are your favorite spring destinations in and around the city?
Spring baseball at Yankee Stadium!
